Constipation, a common gastrointestinal disorder, often presents a diagnostic and therapeutic challenge. This article aims to elucidate a comprehensive approach to its diagnosis and treatment, enabling physicians to effectively manage this condition.
Diagnosis primarily relies on patients' symptoms, with Rome IV criteria being the standard. However, it's crucial to consider differential diagnoses, including irritable bowel syndrome and opioid-induced constipation. A thorough medical history, physical examination, and, if necessary, additional diagnostic tests such as colonoscopy or transit studies can help rule out secondary causes.
First-line treatment typically involves lifestyle modifications and over-the-counter remedies. Dietary changes, such as increasing fiber and fluid intake, can significantly improve symptoms. Osmotic laxatives are often effective, while stimulant laxatives are reserved for short-term use.
For patients unresponsive to first-line treatment, second-line options include prescription drugs such as lubiprostone, linaclotide, and plecanatide. These agents work by increasing intestinal fluid secretion and accelerating transit, thereby alleviating constipation. However, they may cause side effects like diarrhea and abdominal pain.
In refractory cases, biofeedback therapy or surgical intervention may be considered. Biofeedback is particularly beneficial for patients with dyssynergic defecation. Surgery, while rarely used, is an option for severe cases of slow-transit constipation or rectal prolapse.
Understanding constipation's complexity and adopting a comprehensive approach to its diagnosis and treatment is essential for effective patient management. By tailoring the approach to individual patient needs, physicians can significantly improve their patients' quality of life and reduce the burden of this common condition.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation